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Sir,
The article by Ebrahimi-Mamaghani M et al. is quite
informative and focuses on insulin resistance and lipid
profile [1]. We work in a research organization which
supports extramural and intramural research and would
therefore like to know more on some aspects of this
study as stated below.
1. The authors state that lipid abnormality may occur
in polycystic ovary syndrome (PCOS) irrespective of
insulin resistance (IR) in overweight and obese
women. Indian literature showed that about one
fourth of PCOS women have normal body mass
index (BMI) [2]. PCOS women with normal BMI are
very difficult to treat and monitor. Does the lipid
abnormality exit in this category of women also, and
will it help in monitoring of the PCOS women with
normal BMI?
2. The main focus of this study is on overweight and
obese PCOS women. This classification is dependent
on BMI, but waist circumference has not been
considered. However, many studies indicate that
waist circumference is a more sensitive parameter to
define obesity [3, 4]. We would like to know
whether authors have found any relationship
between waist circumference, hyperlipidemia, and
IR. This information is important in monitoring
response of the patients to treatment. Reduction
in waist circumference is a non-invasive indicator
of successful treatment and will be useful in
low-resource settings also.
3. In the present study, prevalence of IR is 36.7 %,
which is higher than that of previously reported
studies [5]. Obesity is the underlying cause of the
development of IR. Is this high prevalence reported
largely because of the overweight and obese women?
We would like to know whether the authors
recommend IR documentation in all the PCOS
women irrespective of BMI and whether IR
investigation would be helpful in monitoring
treatment in PCOS women irrespective of BMI.
4. Age has been reported as an important factor in the
development of PCOS. IR and obesity also develop
over a period of time and increase with age [6].
We would request the authors to discuss the
relationship of IR in different age groups in a
study population.
5. The authors have reported lower testosterone level
among patients with IR. What would be the
suggested underlying mechanism for this finding?
Did they find any relationship with estrogen level?
Free testosterone level has a positive correlation
with HOMA-IR in postmenopausal women but not
in premenopausal women [7]. Postmenopausal
women are considered to have lower estrogenic
levels than premenopausal women. In this respect,
knowing estrogen level in PCOS women is
important.
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